Omega Therapeutics Names Kaan Certel as CEO

Dow Jones

2024-11-15

By Kailyn Rhone

Omega Therapeutics appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company.

Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons.

Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma.

Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition.

Write to Kailyn Rhone at kailyn.rhone@wsj.com

(END) Dow Jones Newswires

November 14, 2024 17:28 ET (22:28 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2483359601"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483359601\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2483359601?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 06:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483359601","market":"sg","top_or_hot":-1,"title":"Omega Therapeutics Names Kaan Certel as CEO","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kailyn Rhone \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/OMGA\">Omega Therapeutics</a> appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company. \n</p>\n<p>\n  Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons. \n</p>\n<p>\n  Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma. \n</p>\n<p>\n  Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition. \n</p>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 17:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omega Therapeutics Names Kaan Certel as CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmega Therapeutics Names Kaan Certel as CEO\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-11-15 06:28</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kailyn Rhone \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/OMGA\">Omega Therapeutics</a> appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company. \n</p>\n<p>\n  Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons. \n</p>\n<p>\n  Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma. \n</p>\n<p>\n  Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition. \n</p>\n<p>\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 17:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMGA","symbol_name":"Omega Therapeutics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483359601","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483359601","pubTimestamp":1731623280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Omega Therapeutics appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company.Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons.Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma.Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OMGA":"Omega Therapeutics"},"translate_title":"Omega Therapeutics任命Kaan Certel为首席执行官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMGA":1},"content_text":"By Kailyn Rhone \n\n\nOmega Therapeutics appointed Kaan Certel as chief executive officer of the Cambridge, Mass.-based biotechnology company. \n\n\n  Certel, who has been Omega's chief business officer since May, will succeed Mahesh Karande, who decided to leave the company for personal reasons. \n\n\n  Certel is an industry veteran with over 20 years of experience in the biopharmaceutical field and academia. Before Omega, he served as the chief business officer for BioCity Biopharma. \n\n\n  Under its new leadership, the company plans to focus its capital resources on three prioritized programs in obesity, regenerative medicine and metabolic indications that will leverage its value proposition. \n\n\n  Write to Kailyn Rhone at kailyn.rhone@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 17:28 ET (22:28 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}